Phage therapy efficacy: a review of the last 10 years of preclinical studies.


Journal

Critical reviews in microbiology
ISSN: 1549-7828
Titre abrégé: Crit Rev Microbiol
Pays: England
ID NLM: 8914274

Informations de publication

Date de publication:
Feb 2020
Historique:
pubmed: 25 2 2020
medline: 29 12 2020
entrez: 25 2 2020
Statut: ppublish

Résumé

Due to the rise of multidrug-resistant infections in humans, phage therapy is gaining renewed attention in Western medicine. Despite the increasing number of publications focussed on the isolation, characterization and

Identifiants

pubmed: 32091280
doi: 10.1080/1040841X.2020.1729695
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

78-99

Auteurs

Luís D R Melo (LDR)

CEB - Centre of Biological Engineering, University of Minho, Braga, Portugal.

Hugo Oliveira (H)

CEB - Centre of Biological Engineering, University of Minho, Braga, Portugal.

Diana P Pires (DP)

CEB - Centre of Biological Engineering, University of Minho, Braga, Portugal.

Krystyna Dabrowska (K)

Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland.

Joana Azeredo (J)

CEB - Centre of Biological Engineering, University of Minho, Braga, Portugal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH